Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 02/04/2026 | Q4 | $24.5B | -- | -- | -- | -- |
| 11/05/2025 | Q3 | $23.4B | $23.5B | $10.94 | -- | -- |
| 08/01/2025 | Q2 | $25.8B | $22.8B | $9.22 | -- | -- |
| 05/01/2025 | Q1 | $23.4B | $24.1B | $11.26 | -- | -- |
| 02/04/2025 | Q4 | $25.6B | $24B | $10.79 | -- | -- |
| 11/01/2024 | Q3 | $23.3B | $23.4B | $6.18 | -- | -- |
| 08/01/2024 | Q2 | $21.1B | $24.6B | $11.86 | -- | -- |
| 05/01/2024 | Q1 | $21.7B | $22.4B | $15.12 | -- | -- |
| 02/13/2024 | Q4 | $21.8B | $24.5B | $6.07 | -- | -- |
| 09/30/2023 | Q3 | $22.1B | $22.3B | $4.66 | -- | -- |
| 06/30/2023 | Q2 | -- | $22.9B | $6.05 | -- | -- |
| 03/31/2023 | Q1 | -- | $24.7B | $7.12 | -- | -- |
| 12/31/2022 | Q4 | -- | $25.5B | $6.85 | -- | -- |
| 09/30/2022 | Q3 | -- | $26.8B | $6.04 | -- | -- |
| 06/30/2022 | Q2 | -- | $28.7B | $6.64 | -- | -- |
| 03/31/2022 | Q1 | -- | $27.2B | $7.49 | -- | -- |
| 12/31/2021 | Q4 | -- | $27.9B | $6.20 | -- | -- |
| 09/30/2021 | Q3 | -- | $25.1B | $5.93 | -- | -- |
| 06/30/2021 | Q2 | -- | $24.3B | $5.29 | -- | -- |
| 03/31/2021 | Q1 | -- | $31.2B | $7.66 | -- | -- |
| 12/31/2020 | Q4 | -- | $19.5B | $5.06 | -- | -- |
| 09/30/2020 | Q3 | -- | $17.5B | $2.66 | -- | -- |
| 07/31/2020 | Q2 | -- | $17.2B | $3.43 | -- | -- |
| 05/01/2020 | Q1 | -- | $15.5B | $1.52 | -- | -- |
| 02/04/2020 | Q4 | -- | $16.4B | $2.68 | -- | -- |
| 10/30/2019 | Q3 | -- | $16.6B | $2.92 | -- | -- |
| 07/31/2019 | Q2 | -- | $14.9B | $3.27 | -- | -- |
| 04/26/2019 | Q1 | -- | $17.7B | $1.67 | -- | -- |
| 02/01/2019 | Q4 | -- | $16B | $3.24 | -- | -- |
| 11/09/2018 | Q3 | -- | $14.9B | $2.69 | -- | -- |
| 08/02/2018 | Q2 | -- | $14.3B | $3.12 | -- | -- |
| 05/08/2018 | Q1 | -- | $11.4B | $1.11 | -- | -- |
| 02/02/2018 | Q4 | -- | $11.2B | $3.48 | -- | -- |
| 11/02/2017 | Q3 | -- | $10.9B | $3.26 | -- | -- |
| 08/03/2017 | Q2 | -- | $10.6B | $2.82 | -- | -- |
| 05/09/2017 | Q1 | -- | $10.5B | $1.88 | -- | -- |
| 02/08/2017 | Q4 | -- | $10.4B | $2.76 | -- | -- |
| 11/02/2016 | Q3 | -- | $9.9B | $1.66 | -- | -- |
| 08/03/2016 | Q2 | -- | $9.5B | $1.58 | -- | -- |
| 03/31/2016 | Q1 | -- | $9.4B | -$5.28 | -- | -- |
| 12/31/2015 | Q4 | -- | $9.7B | $0.09 | -- | -- |
Mitsui & Co., Ltd. reported $23.5B worth of top line sales in its most recent quarter.
Mitsui & Co., Ltd. announced earnings per share of $10.94 which represents a beat of analyst forecast a -- per share.
Mitsui & Co., Ltd. reported $2.2B that represents $14.50 per share over the last quarter.
Mitsui & Co., Ltd.'s earnings are forecast to grow from $40.21 per share to -- per share next year representing an increase of --.
Mitsui & Co., Ltd.'s next earnings date is February 4, 2026.
Signup to receive the latest stock alerts
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Market Cap: $4.6T
P/E Ratio: 64x
Market Cap: $4T
P/E Ratio: 37x
Market Cap: $3.8T
P/E Ratio: 39x
Hut 8 Corp. [HUT] is up 0.65% over the past day.
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Structure Therapeutics, Inc. [GPCR] is down 2.36% over the past day.